Imiquimod Cream
Product Images NDC 68462-536

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 68462-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn24

The text describes a medication product in the form of 24 single-use packets containing 12.5 mg of imiquimod USP for dermatologic use. It also mentions the inactive ingredients in the composition, the manufacturer, and provides dosage recommendations and storage information. The package is not child-resistant and the product should be kept out of reach of children. The contact information for any queries is also provided.*

FDA Label Image

Figure1

This text seems to be a table presenting the results of a clinical trial related to the efficacy of Imiquimed Cream Vehicle in treating a condition. The trial involved 209 patients, among which 109 completed the 16 weeks of treatment with the cream, while 100 withdrew from treatment for reasons that are not clear. Out of the 109 patients who completed the treatment, 19 had unclear results, while 36 had clear results. The remaining 62 patients who withdrew or did not complete the treatment do not have clear results. Additionally, 9 patients remained clear after completing 12 weeks of follow-up.*

FDA Label Image

Logo

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.